Stifel analyst Rick Wise lowered the firm’s price target on GE HealthCare (GEHC) to $90 from $104 and keeps a Buy rating on the shares. Despite tariff-related margin and EPS pressures, it is “clear” from the Q1 earnings call that the company’s “underlying business momentum continues to head in a positive direction,” the analyst tells investors. Encouraging for the company’s longer-term outlook, management highlighted that strong order growth performance is indicative of share gains across “a significant number of markets where we compete,” the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target lowered to $86 from $105 at Citi
- Resilient Growth Amidst Challenges: Buy Rating for GE Healthcare Technologies Inc.
- GE HealthCare price target lowered to $82 from $95 at BTIG
- Early notable gainers among liquid option names on April 30th
- Morning Movers: Norwegian Cruise Line falls following first quarter results